Related Experiment Videos

Roles of human epicardial adipose tissue in coronary artery atherosclerosis

Xinzhong Chen1, Zhouyang Jiao, Lei Wang

  • 1Department of Cardiovascular Surgery, Huazhong University of Science and Technology, Wuhan, China. xinzhongchen@yahoo.com.cn

Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban
|November 11, 2010
PubMed

Insights

Epicardial adipose tissue inflammation is linked to coronary artery disease (CAD). Lower adiponectin levels in CAD patients suggest its role in disease development.

Area of Science:

  • Cardiovascular Research
  • Metabolic Syndrome
  • Inflammation Biology

Background:

  • Epicardial adipose tissue (EAT) is metabolically active and influences coronary artery health.
  • Adipocytokines secreted by EAT may play a role in the pathogenesis of coronary artery disease (CAD).
  • Understanding the specific interactions between EAT and vascular disease is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the relationship between epicardial adipose tissue and coronary artery atherosclerosis.
  • To compare adipocytokine levels and gene expression in patients with and without coronary artery disease.
  • To elucidate the role of local inflammation in epicardial adipose tissue in CAD pathogenesis.

Main Methods:

  • Comparative analysis of plasma adipocytokine levels (adiponectin, IL-10, TNF-α) using ELISA in 34 patients.
  • Assessment of adiponectin and CD68 expression in epicardial and subcutaneous adipose tissue via RT-PCR and immunohistochemistry.
  • Stratification of patients into non-coronary artery disease (Group I) and coronary artery disease (Group II) groups.

Main Results:

  • Plasma adiponectin levels were significantly lower in the coronary artery disease group (Group II) compared to the non-coronary artery disease group (Group I).
  • No significant differences were observed in plasma IL-10, TNF-α, total cholesterol, HDL-cholesterol, or LDL-cholesterol between the groups.
  • Epicardial adipose tissue in Group II showed increased CD68+ cell infiltration and significantly lower adiponectin mRNA expression compared to subcutaneous adipose tissue and Group I.

Conclusions:

  • Local inflammation within epicardial adipose tissue is implicated in the pathogenesis of coronary artery disease.
  • Reduced adiponectin expression in epicardial adipose tissue may contribute to the development of atherosclerosis.
  • Epicardial adipose tissue serves as a potential indicator and contributor to coronary artery disease progression.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypodermis01:02

Hypodermis

The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
Inflammation01:38

Inflammation

Overview